IMB supports Georgian partners with Covid-19 diagnostics

Up to now, more than 45.000 people were reported to be infected with the novel Coronavirus, of which over 1000 died as a consequence of the disease. The virus can be transmitted from person to person and has already spread to over 20 countries worldwide. In Germany, the first cases of Covid-19 (previously 2019-nCov) infections were diagnosed at the Bundeswehr Institute of Microbiology (IMB) (https://instmikrobiobw.de/aktuelles). 

Since 2013, the IMB collaborates with the National Center for Disease Control and Public Health (NCDC) in Tbilisi (Georgia) within the framework of the German Biosecurity Programme. The NCDC is the national agency responsible for health and bio-surveillance and the control of infectious diseases in Georgia. To enable our Georgian partners to diagnose Covid-19, the IMB supported with material and technical knowledge to establish the diagnostic assay at the NCDC. The scientific staff of the NCDC were able to implement the assay immediately to diagnose suspected persons. The training to establish and validate reliable diagnostics has always been an integral part of the biosecurity project in Georgia and demonstrates in this acute outbreak situation its value.